谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

An Open-Label Phase II Study of Dostarlimab (TSR-042), Bevacizumab (bev), and Niraparib Combination in Patients (pts) with Platinum-Resistant Ovarian Cancer (PROC): Cohort A of the OPAL Trial

Joyce Liu,Stephanie Gaillard,Andrea Wahner Hendrickson,John Moroney,Oladapo Yeku,Elisabeth Diver,Camille Gunderson,Rebecca Arend,Elena Ratner,Vivek Samnotra,Divya Gupta,Lena Evilevitch,Sarah Wang,Ping Wang, Joseph Tang,Emeline Bacque, Xiaohong Liu,Gottfried Konecny

Gynecologic Oncology（2021）

引用 16|浏览26
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要